Where do Stoke Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-577.5%-597pp	-11.2%+266pp	13.2%+714pp	20.2%+776pp	20%+1,530pp
Net margin	-529.2%-556pp	-3.7%+240pp	19.7%+650pp	26.3%+710pp	26.3%+1,410pp
Returns
Return on equity	-45.6%-66.1pp	-2.4%+43.4pp	15%+67.1pp	18.2%+66.0pp	20.5%+81.8pp
Return on invested capital	-114.4%—	-10.9%—	17.3%—	27.4%+429pp	——
Efficiency
Asset turnover	0.1×-0.5×	0.5×+0.4×	0.6×+0.6×	0.6×+0.5×	0.6×+0.6×
Liquidity
Current ratio	9×+0.6×	5.3×-0.5×	6.5×+1.4×	7×+0.3×	8.4×+3.0×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$6.26+6.2%	$5.95+40.4%	$5.26+27.6%	$5.74+31.9%	$5.89+94.2%
Valuation
Market capitalization	$1.93B+436%	$1.81B+210%	$1.29B+87.9%	$628.41M+0.6%	$359.62M-42.4%
Price / sales	60×+58.2×	9.8×-6.2×	6.3×-34.7×	3.1×-38.1×	1.9×-77.7×
Price / book	4.9×+3.8×	5.1×+2.6×	4.2×+1.2×	1.9×-0.7×	1×-3.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Stoke Therapeutics, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Stoke Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.